
Science – Good News Network
shared a link post in group #Good News Only

www.goodnewsnetwork.org
Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients
A drug that targets the deadliest form of breast cancer has recently been found to elicit 75% immune responses with no side effects.